Quantbot Technologies LP Sells 11,635 Shares of Koninklijke Philips N.V. $PHG

Key Points

• Quantbot Technologies LP decreased its holdings in Koninklijke Philips N.V. by 20.0%, owning 46,567 shares valued at approximately $1.18 million after selling 11,635 shares in the first quarter.
• Other hedge funds notably increased their positions, with QRG Capital Management Inc. raising its stake by 11.0% and Quantinno Capital Management LP boosting theirs by 71.1%.
• Wall Street analysts have downgraded Koninklijke Philips from a "buy" to a "hold" rating, despite the stock recently trading up 3.2% to $28.31.

Quantbot Technologies LP decreased its position in Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 20.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,567 shares of the technology company's stock after selling 11,635 shares during the period. Quantbot Technologies LP's holdings in Koninklijke Philips were worth $1,183,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of PHG. Colonial Trust Co SC raised its holdings in Koninklijke Philips by 724.0% during the 4th quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company's stock valued at $36,000 after acquiring an additional 1,238 shares during the period. Bessemer Group Inc. raised its holdings in Koninklijke Philips by 2,935.4% during the 1st quarter. Bessemer Group Inc. now owns 1,973 shares of the technology company's stock valued at $51,000 after acquiring an additional 1,908 shares during the period. Caitong International Asset Management Co. Ltd raised its holdings in Koninklijke Philips by 1,170.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,439 shares of the technology company's stock valued at $62,000 after acquiring an additional 2,247 shares during the period. Castlekeep Investment Advisors LLC bought a new position in shares of Koninklijke Philips in the fourth quarter worth $114,000. Finally, Allworth Financial LP increased its holdings in shares of Koninklijke Philips by 16.2% in the first quarter. Allworth Financial LP now owns 4,638 shares of the technology company's stock worth $115,000 after purchasing an additional 645 shares during the period. Institutional investors own 13.67% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen cut shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Koninklijke Philips currently has a consensus rating of "Buy".

Koninklijke Philips Trading Up 0.0%

NYSE PHG traded up $0.01 during trading on Friday, hitting $27.59. 1,019,659 shares of the company's stock traded hands, compared to its average volume of 813,772. The stock has a fifty day moving average of $25.76 and a two-hundred day moving average of $25.03. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.26 and a quick ratio of 0.81. Koninklijke Philips N.V. has a 12-month low of $21.48 and a 12-month high of $32.91. The firm has a market cap of $26.56 billion, a P/E ratio of 145.18, a PEG ratio of 0.75 and a beta of 0.75.

Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The technology company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.12. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. The company had revenue of $5.05 billion during the quarter, compared to analyst estimates of $4.35 billion. As a group, sell-side analysts expect that Koninklijke Philips N.V. will post 1.63 EPS for the current year.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.